Oppenheimer & CO Inc United Therapeutics Corp Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Oppenheimer & CO Inc holds 6,248 shares of UTHR stock, worth $2.41 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,248

Previous 5,170 20.85%

Holding current value

$2.41 Million

Previous $1.65 Million 35.97%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$311.04 - $363.55 $335,301 - $391,906	1,078 Added 20.85%	6,248 $2.24 Million
Q2 2024 Aug 07, 2024	BUY	$228.26 - $319.04 $120,977 - $169,091	530 Added 11.42%	5,170 $1.65 Million
Q1 2024 May 06, 2024	BUY	$210.76 - $249.51 $147,321 - $174,407	699 Added 17.74%	4,640 $1.07 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $108,514 - $129,754	505 Added 14.7%	3,941 $866,000
Q3 2023 Nov 07, 2023	SELL	$211.82 - $248.24 $815,507 - $955,724	-3,850 Reduced 52.84%	3,436 $776,000
Q2 2023 Aug 02, 2023	BUY	$205.19 - $232.99 $148,147 - $168,218	722 Added 11.0%	7,286 $1.61 Million
Q1 2023 May 10, 2023	SELL	$212.99 - $276.17 $140,360 - $181,996	-659 Reduced 9.12%	6,564 $1.47 Million
Q4 2022 Feb 07, 2023	SELL	$205.95 - $280.43 $425,080 - $578,807	-2,064 Reduced 22.22%	7,223 $2.01 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $551,552 - $662,433	2,713 Added 41.27%	9,287 $1.95 Million
Q2 2022 Aug 08, 2022	BUY	$174.81 - $241.14 $569,181 - $785,151	3,256 Added 98.13%	6,574 $1.55 Million
Q1 2022 May 12, 2022	SELL	$166.16 - $213.96 $65,799 - $84,728	-396 Reduced 10.66%	3,318 $595,000
Q4 2021 Feb 02, 2022	BUY	$184.32 - $216.08 $33,914 - $39,758	184 Added 5.21%	3,714 $803,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $120,506 - $143,969	670 Added 23.43%	3,530 $652,000
Q2 2021 Aug 03, 2021	SELL	$170.47 - $211.93 $36,480 - $45,353	-214 Reduced 6.96%	2,860 $513,000
Q1 2021 May 10, 2021	BUY	$153.94 - $174.85 $60,344 - $68,541	392 Added 14.62%	3,074 $514,000
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $3,463 - $5,160	-34 Reduced 1.25%	2,682 $407,000
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $257,941 - $312,757	-2,582 Reduced 48.74%	2,716 $274,000
Q2 2020 Aug 11, 2020	BUY	$92.74 - $125.82 $491,336 - $666,594	5,298 New	5,298 $641,000
Q1 2020 May 08, 2020	SELL	$79.39 - $115.35 $406,556 - $590,707	-5,121 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$74.85 - $85.99 $94,834 - $108,949	1,267 Added 32.87%	5,121 $408,000
Q2 2019 Aug 09, 2019	BUY	$76.06 - $120.81 $293,135 - $465,601	3,854 New	3,854 $301,000
Q1 2018 May 01, 2018	SELL	$107.21 - $151.94 $173,251 - $245,535	-1,616 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$118.58 - $151.28 $191,625 - $244,468	1,616	1,616 $239,000

Others Institutions Holding UTHR

# of Institutions

657

Shares Held

42.8M

Call Options Held

153K

Put Options Held

278K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc United Therapeutics Corp Transaction History